awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q33410481-AB2267CA-9E39-440A-8839-D4685145290D
Q33410481-AB2267CA-9E39-440A-8839-D4685145290D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33410481-AB2267CA-9E39-440A-8839-D4685145290D
Vorinostat or placebo in combination with bortezomib in patients with multiple myeloma (VANTAGE 088): a multicentre, randomised, double-blind study.
P1433
Q33410481-AB2267CA-9E39-440A-8839-D4685145290D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33410481-AB2267CA-9E39-440A-8839-D4685145290D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0a178b982b58c49307d71f1b5b34df9b6ac67cb4
P1433
The Lancet Oncology